Atlas FDA

CELLEX PROCEDURAL KIT

FDA premarket approval P860003/S056 · decided 2010-12-09

Approval details

PMA number
P860003
Supplement
S056
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
CELLEX PROCEDURAL KIT
Generic name
System, photopheresis, extracorporeal
Applicant
Therakos Development Limited
Date received
2010-11-12
Decision date
2010-12-09
Days to decision
27 days
Decision code
OK30
Product code
LNR
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Dublin
Statement
CHANGE TO A COMPONENT MANUFACTURING PROCEDURE AND A CHANGE TO A TEST METHOD.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.